155 related articles for article (PubMed ID: 11181688)
1. Adjuvant therapy of melanoma: at what cost?
Spitler LE
J Clin Oncol; 2001 Feb; 19(4):1226-8. PubMed ID: 11181688
[No Abstract] [Full Text] [Related]
2. Adjuvant interferon alfa-2b for high-risk melanoma.
Retsas S
J Clin Oncol; 1996 Jun; 14(6):1968-9. PubMed ID: 8656272
[No Abstract] [Full Text] [Related]
3. [Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].
Hauschild A; Dummer R; Garbe C; Kaufmann R; Schadendorf D; Soyer HP; Stadler R; Tilgen W
Hautarzt; 1998 Mar; 49(3):167-9. PubMed ID: 9565782
[No Abstract] [Full Text] [Related]
4. [Interferon therapy in malignant melanoma].
Kokoschka EM; Micksche M
Wien Med Wochenschr; 1993; 143(16-17):441-2. PubMed ID: 8273369
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy of melanoma.
Retsas S
Lancet; 1998 Aug; 352(9129):737-8. PubMed ID: 9729017
[No Abstract] [Full Text] [Related]
6. Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity.
Eggermont AM; Suciu S; Rutkowski P; Kruit WH; Punt CJ; Dummer R; Salès F; Keilholz U; de Schaetzen G; Testori A;
Eur J Cancer; 2016 Mar; 55():111-21. PubMed ID: 26790144
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
Johnson DM; Hayat SQ; Burton GV
J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
[No Abstract] [Full Text] [Related]
8. Adjuvant IFN alpha2 therapy of melanoma.
Kirkwood JM
Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
[No Abstract] [Full Text] [Related]
9. Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma.
Bajetta E
Nat Clin Pract Oncol; 2008 Jan; 5(1):4-5. PubMed ID: 18043604
[No Abstract] [Full Text] [Related]
10. Does adjuvant vaccine therapy really have activity in malignant melanoma?
Wheatley K; Ives NJ; Lorigan P
J Clin Oncol; 2007 Oct; 25(29):4693; author reply 4693-5. PubMed ID: 17925569
[No Abstract] [Full Text] [Related]
11. Adjuvant interferon in the treatment of melanoma.
Middleton MR
Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
[No Abstract] [Full Text] [Related]
12. Interferon adjuvant therapy of melanoma.
Kirkwood JM; Wazer D; Rosenstein M
Cancer; 1997 May; 79(9):1843-6. PubMed ID: 9129006
[No Abstract] [Full Text] [Related]
13. The adjuvant treatment of malignant melanoma.
Reintgen D; Kirkwood J
J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
[TBL] [Abstract][Full Text] [Related]
14. Clinical prognostic factors in adjuvant melanoma trial.
Nathanson L
J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
[No Abstract] [Full Text] [Related]
15. Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data.
Kilbridge KL; Cole BF; Kirkwood JM; Haluska FG; Atkins MA; Ruckdeschel JC; Sock DE; Nease RF; Weeks JC
J Clin Oncol; 2002 Mar; 20(5):1311-8. PubMed ID: 11870174
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of cutaneous melanoma].
Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G
Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818
[TBL] [Abstract][Full Text] [Related]
17. [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
Bernengo MG; Doveil GC; Appino A; Sertoli MR; Ardizzoni A; Vidili MG
G Ital Dermatol Venereol; 1988 Apr; 123(4):185-8. PubMed ID: 3182009
[No Abstract] [Full Text] [Related]
18. Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease.
Lens M
Dermatol Ther; 2006; 19(1):9-18. PubMed ID: 16405565
[TBL] [Abstract][Full Text] [Related]
19. Finally, a successful adjuvant therapy for high-risk melanoma.
Balch CM; Buzaid AC
J Clin Oncol; 1996 Jan; 14(1):1-3. PubMed ID: 8558183
[No Abstract] [Full Text] [Related]
20. Malignant melanoma: non-metastatic.
Crosby D; Crosby T; Mason M
Clin Evid; 2002 Jun; (7):1519-29. PubMed ID: 12230768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
